Maxim Group Maintains Buy on Compass Pathways, Raises Price Target to $20
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Maxim Group analyst Jason McCarthy maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $12 to $20.
Maxim Group analyst Jason McCarthy maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $12 to $20.